Search Results for 'trial stroke'

trial stroke published presentations and documents on DocSlides.

Stroke Hyperglycemia Insulin
Stroke Hyperglycemia Insulin
by celsa-spraggs
Network Effort (SHINE) Trial . NIH-NINDS . U01 . ...
CANCER AND STROKE ________________________
CANCER AND STROKE ________________________
by rudy699
Michela Rosso. CANCER AND STROKE. CANCER and VTE. ...
Efficiency of recruitment to stroke rehabilitation RCTs
Efficiency of recruitment to stroke rehabilitation RCTs
by liane-varnes
Secondary analysis of recruitment data. Kris McGi...
2015 ISC Hot Topics- Advancing Your Stroke Program
2015 ISC Hot Topics- Advancing Your Stroke Program
by calandra-battersby
Debbie Summers, MSN, RN, ACNS-BC, CNRN, SCRN, FAH...
Risk Factor Modification Post Stroke
Risk Factor Modification Post Stroke
by olivia-moreira
Ron Pellegrino, MD. November 20, 2015. Objectives...
Treating Acute Ischemic Stroke,
Treating Acute Ischemic Stroke,
by kittie-lecroy
Can We Open Up the Time Window. ?. David Wang, ...
2015 ISC Hot Topics- Advancing Your Stroke Program
2015 ISC Hot Topics- Advancing Your Stroke Program
by goldengirl
Debbie Summers, MSN, RN, ACNS-BC, CNRN, SCRN, FAHA...
The New Frontier In Stroke Care –
The New Frontier In Stroke Care –
by discoverfe
Endovascular Intervention. Syed F Ali. Chief Resid...
Ticagrelor ADDED to aspirin in Acute NON-SEVERE ISCHEMIC Stroke OR TIA OF ATHEROSCLEROTIC
Ticagrelor ADDED to aspirin in Acute NON-SEVERE ISCHEMIC Stroke OR TIA OF ATHEROSCLEROTIC
by eloise
ORIGIN. Pierre . Amarenco. , Hans . Denison. , . S...
Rethinking TIA  and Minor Stroke
Rethinking TIA and Minor Stroke
by molly
S. Claiborne Johnston, MD, PhD. Dell Medical Schoo...
R APID
R APID
by giovanna-bartolotta
I. NTERVENTION WITH . G. TN IN . H. YPERACUTE STR...
Strategies to Reduce  Door-to-Puncture Times
Strategies to Reduce Door-to-Puncture Times
by celsa-spraggs
in Acute Stroke. Gregory W. Albers, MD: . Time is...
Randomized trial of manual aspiration Thrombectomy + PCI vs
Randomized trial of manual aspiration Thrombectomy + PCI vs
by olivia-moreira
SS Jolly, JA . Cairns, . S . Yusuf, . B . Meeks, ...
Stroke or systemic embolic events in large NOAC trials, vs
Stroke or systemic embolic events in large NOAC trials, vs
by faustina-dinatale
Ruff . et al. ., The Lancet, 2013. Ruff . et al. ...
Management of asymptomatic 			carotid stenosis
Management of asymptomatic carotid stenosis
by trish-goza
Thomas C. Hammond M.D., FAAN. UCNS certified in N...
RAPID INTERVENTION WITH GTN IN HYPERACUTE STROKE
RAPID INTERVENTION WITH GTN IN HYPERACUTE STROKE
by test
RAPID INTERVENTION WITH GTN IN HYPERACUTE STROKE T...
Qu a r t er l y   N e w sle
Qu a r t er l y N e w sle
by ishaan
tt. er. Brain. . modulation. . for. . Neuroreco...
Stephanie M. Wilbrand, PhD
Stephanie M. Wilbrand, PhD
by emma
STROKENET RESOURCES FOR STUDY COORDINATORS . AND P...
NINDS team :  	Scott Janis
NINDS team : Scott Janis
by gagnon
Joanna Vivalda. Claudia Moy. Carlos Faraco . P...
wwwstrokeassemblyorguk                          strokeassembly
wwwstrokeassemblyorguk strokeassembly
by susan
Stroke and Dementia: what research tells us UK St...
Antiplatelet  therapy (n = 126)
Antiplatelet therapy (n = 126)
by PlayfulSpirit
Anticoagulant therapy. (n = . 124). CADISS. P. rim...
The case for intensive lipid management:
The case for intensive lipid management:
by SillyGoose
The opportunities and issues for cardiologists. Pr...
Three Cases Vanja  Douglas, MD
Three Cases Vanja Douglas, MD
by eliza
Sara & Evan Williams Foundation Endowed . Neur...
Landmark  statin  trials a
Landmark statin trials a
by hadly
cross . the . spectrum . of . risk. : . Secondary ...
ACST-2:  Randomised trial of stenting vs surgery
ACST-2: Randomised trial of stenting vs surgery
by melanie
for asymptomatic severe carotid artery stenosis. ...
THERAPY Trial
THERAPY Trial
by celsa-spraggs
ESO Conference. Glasgow, Scotland. April 17, 2015...
The DEFLECT III Trial:
The DEFLECT III Trial:
by pasty-toler
A Prospective Randomized Evaluation of the . TriG...
Novel antithrombotic agents in acute coronary syndromes: be
Novel antithrombotic agents in acute coronary syndromes: be
by jane-oiler
n . P2Y12 inhibitors. Giuseppe Biondi Zoccai. Sap...
Prevention Trials: Operational Challenges and
Prevention Trials: Operational Challenges and
by phoebe-click
Prevention Trials: Operational Challenges and Oppo...
1 year results of the TOTAL trial:
1 year results of the TOTAL trial:
by pressio
Randomized trial of manual . Thrombectomy. in STE...
Stress, Anxiety & Depression:
Stress, Anxiety & Depression:
by giovanna-bartolotta
So What Do I Take?. Gary E. Foresman, MD. July 20...
 IMPACT- AFib : An 80,000 Person Randomized Trial Using the
IMPACT- AFib : An 80,000 Person Randomized Trial Using the
by celsa-spraggs
FDA Sentinel System Platform . Richard Platt, MD,...
Two-year Clinical and Echocardiographic Outcomes from the PARTNER 3  Low-risk Randomized Trial
Two-year Clinical and Echocardiographic Outcomes from the PARTNER 3 Low-risk Randomized Trial
by braylen673
Low-risk Randomized Trial. Michael J. Mack, . MD &...
Update on Carotid Disease:
Update on Carotid Disease:
by vivian
CEA – Surgery and β€˜Best’ medical treatmen...
Effects of antiplatelet therapy after stroke due to
Effects of antiplatelet therapy after stroke due to
by pamela
intracerebral haemorrhage (ICH): extended follow-u...
Pragmatic Clinical Trials:   Challenges with Clinical Event Ascertainment using
Pragmatic Clinical Trials: Challenges with Clinical Event Ascertainment using
by anastasia
RWD. Frank W. Rockhold, PhD. Professor of Biostati...
StrokeNet Coordinator Webinar
StrokeNet Coordinator Webinar
by brooke
April 28, 2021 . StrokeNet Acronyms . Acronym - . ...
Empagliflozin  in  Heart
Empagliflozin in Heart
by brooke
. Failure. . with. a . Preserved. Ejection Frac...